top of page

News
Search


TestAVec Researchers Uncover Possible Reasons For Side Effects of HIV-1 Lentiviral Vectors
TestAVec CSO, Professor Michael Themis, also Head of the Gene Therapy research group at Brunel University London, and his team have...
May 12, 2022


Merry Christmas from TestAVec
From all of us at TestAVec, we wish you a wonderful Christmas and new year. We look forward to working with you in 2022.
Dec 24, 2021


The real patient benefit of gene therapy highlighted by skin transplant
In 2015, a 7 year old patient was presented at a hospital in Germany with severe burns. The patient had suffered debilitating blisters...
Dec 9, 2021
Promising gene therapy trial for haemophillia
A Phase 1/2 gene therapy trial conducted at the Children's hospital of Philadelphia have shown promising results in the treatment of...
Nov 23, 2021


Positive news for DMD gene therapy
Recent clinical trial results for SRP-9001 show high levels of sustained improvements in patients suffering from Duchene muscular...
Oct 15, 2021
bottom of page